Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia

Chih Chen Hong, Jong Ding Lay, Jhy Shrian Huang, Ann Lii Cheng, Jih Luh Tang, Ming Tseh Lin, Gi Ming Lai, Shuang En Chuang

研究成果: 雜誌貢獻文章

128 引文 斯高帕斯(Scopus)


By using a novel profiling analysis of protein tyrosine kinases differentially expressed in the sensitive and refractory leukemia from the same patients we found that AXL was upregulated in drug-resistant leukemia. Furthermore, AXL could be induced by chemotherapy drugs in the acute myeloid leukemia U937 cells and this induction was dependent on the CCWGG methylation status of the AXL promoter. In U937 cells ectopically overexpressing AXL, addition of exogenous Gas6 induced AXL phosphorylation and activation of the Akt and ERK1/2 survival pathways. The Gas6-AXL activation pathway of drug resistance was associated with increased expression of Bcl-2 and Twist. These results show that upregulation of AXL by chemotherapy might induce drug resistance in acute myeloid leukemia in the presence of Gas6 stimulation.

頁(從 - 到)314-324
期刊Cancer Letters
出版狀態已發佈 - 九月 18 2008


ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology